Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT06503406
NA
A Prospective Study Using SupraSDRM® in Promoting Healing and Reducing the Time to Grafting of Full-thickness Wounds
Sponsor: The Metis Foundation
View on ClinicalTrials.gov
Summary
This is a prospective, randomized, controlled, multi-center clinical study comparing SupraSDRM® to standard of care wound dressing, BTM, in the treatment of full-thickness wounds deemed not immediately suitable for definitive grafting will be performed.
Key Details
Gender
All
Age Range
18 Years - 85 Years
Study Type
INTERVENTIONAL
Enrollment
24
Start Date
2025-03
Completion Date
2026-10
Last Updated
2025-02-21
Healthy Volunteers
No
Conditions
Interventions
DEVICE
SupraSDRM®
SupraSDRM® Bidegradable Matrix Wound Dressing is a tri-polymber, Biodegrable dermal covering manufactured by PolyMedics Innovations, GmbH.
DEVICE
NovoSorb® BTM
NovoSorb® BTM absorbable synthetic wound dressing, PolyNovo Biomaterials, K172140